Omnicell (OMCL) Net Equity Issued and Repurchased (2019)
Omnicell's (OMCL) quarterly Net Equity Issued and Repurchased came in at $17.6 million in Q2 2019, down 12.99% on a QoQ basis from $20.2 million in Q1 2019.
Omnicell (OMCL) Net Equity Issued and Repurchased (2019) Analysis & Trends
Omnicell (OMCL) has 1 years of Net Equity Issued and Repurchased data on file, last reported at $17.6 million in Q2 2019.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $17.6 million in Q2 2019; TTM through Mar 2020 was $17.6 million, a N/A change from a year earlier, with the FY2019 full-year figure at $37.8 million, down 4.45% from the prior year.
- Net Equity Issued and Repurchased for Q2 2019 stood at $17.6 million, down from $20.2 million in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for OMCL reached as high as $20.2 million in Q1 2019 and fell as low as $17.6 million in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.74 Bn | 24.42 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 14.63 Bn | 13.73 Bn | 482.22 Mn | - |
| 3 | Healthequity | 8.31 Bn | 8.05 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 5.95 Bn | 5.64 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 5.79 Bn | 5.26 Bn | 106.18 Mn | - |
| 6 | MiniMed | 4.52 Bn | 4.22 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.46 Bn | 4.40 Bn | 216.84 Mn | - |
| 8 | Doximity | 3.96 Bn | 3.22 Bn | 125.97 Mn | - |
| 9 | Privia Health | 3.17 Bn | 2.75 Bn | - | - |
| 10 | Omnicell | 1.86 Bn | 1.62 Bn | 140.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 17.59 Mn |
| Jun 30, 2019 | 17.59 Mn |
| Mar 31, 2019 | 20.22 Mn |
| Mar 31, 2019 | 20.22 Mn |